Woodline Partners »

Teva Pharmaceutical Industries shares owned by Woodline Partners

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $19M 1.0M 18.02
2024-06-30 $17M 1.0M 16.25
2024-03-31 $15M 1.0M 14.11
2022-06-30 $15M 2.0M 7.52

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Teva Pharmaceutical Industries

BlackRock
BlackRock
Ion Asset Management
Clal Insurance Enterprises Holdings
Exor Investments
Migdal Insurance & Financial Holdings
Phoenix Holdings
State Street Corporation
Rubric Capital Management
Arrowstreet Capital, Limited Partnership
Slate Path Capital
Morgan Stanley
PointState Capital
Geode Capital Management
Glenview Captal Management

View all funds holding Teva Pharmaceutical Industries